Evan Shlofmitz
@ESHLOF
Followers
2K
Following
5K
Media
35
Statuses
2K
New York, USA
Joined September 2011
@StFrancis_LI strong 💪. Leading the way in FORWARD CAD. Our first 31 patient experience with the Javelin IVL microcatheter. Making the uncrossable, crossable. Cant wait to have it back! @ShockwaveIVL @djc795 @ESHLOF @ColletCarlos @DrAllenJ
3
5
36
📢FELLOWS: CALL FOR CASES. Submit a case for the OPCI Structural Complications Summit 2026 in Salt Lake City upon registration. If selected, OPCI will cover airfare and 2-night stay. ✨January 16 -17 📅 Register now: https://t.co/Bjfgau3pZU Stay and ski MLK weekend 🏔️⛷️Reserve
0
2
4
Ever wondered why some pts feel every balloon inflation, while others feel nothing? 💭 Or why severe ischemia can be asymptomatic? Our placebo-controlled, n-of-1 study — simultaneous in #Circulation & #TCT2025 — shows collateralization may be key. 🔗 https://t.co/uyAw3gXAx3
5
43
121
Thank you to our incredible faculty for sharing their cases at our #TCT2025 symposium yesterday! With the addition of X1-FFR, HyperVue becomes the first system to unite DeepOCT+NIRS imaging with wire-free physiology. Catch our team at Booth 2027 before the show wraps up today
0
2
8
#CoronaryPhysiology
#CoronaryComputedTomography
#TCT2025 N E W : N A V I G A T E P C I registry 👋@ColletCarlos
@yadersandoval
@ESHLOF
@TCTConference
@crfheart
1
1
2
📢Sneak Peak: starting lineup from OPCI at Day 2 of #TCT2025! @ESHLOF @OKhaliqueMD @DrAllenJ @ziadalinyc @CathElectroSurg. 👏Stay tuned for more! 💥 Check out the full program at: https://t.co/P2A4TA7pW4
0
3
10
Watch OPCI Journal Club: “Clopidogrel versus Aspirin for Secondary Prevention of Coronary Artery Disease: a Systematic Review and Individual Patient Data Meta-Analysis." Presented by Dr. Marco Valgimigli along with panelists @djc795 @ziadalinyc @DrAllenJ @ESHLOF @JWMoses and Dr.
0
3
12
It's almost time for #TCT2025! Join @ESHLOF on Sunday, October 26 at 12:40 PM for a presentation of SpectraWAVE's US study results assessing the use of HyperVue for coronary stent optimization! #DeepOCT #ImageFirst #X1FFR
1
2
12
Curious to see how this heavily calcified vessel was treated? Come find out at our upcoming symposium at #TCT2025 in just one week — ‘The Full Picture for PCI Planning: Intravascular Imaging and Angio-Derived FFR.’ Click the link to add to your calendar: https://t.co/sVJmv98mGX
0
5
19
Photon-counting detector CT (PCD-CT) demonstrates high specificity and negative predictive value for detecting in-stent restenosis (ISR) across different stent sizes. These results support its potential role as a reliable non-invasive tool in the follow-up of patients with prior
1
32
78
Free Travel & Hotel for Out of State Fellows | OPCI Michigan 2025 - Nov 22. Register Now! https://t.co/UDKlUcR4rm 🌟For Fellows Traveling More Than 2 Hours: Complimentary 1-night stay at The Westin Book Cadillac plus $300 travel credit to be issued after attending the event. 🌟
0
4
6
Coronary CT will become the non-invasive standard to evaluate patients with stents It will also help in understanding the root cause of stent restenosis (mechanical vs. neoatherosclerosis) and guide treatment @djc795 @ziadalinyc @Heart_SCCT @SCAI @crfheart
5
41
122
Well worth watching this @OPCILive in-depth discussion of the Left Main Physiology study https://t.co/hVjPQiQVb7 done by @DrOzanDemir @AishSinha1 @DrHaseebRahman1 @divaka_perera et al, with @ziadalinyc @djc795 @DrAllenJ @JWMoses @ESHLOF
ahajournals.org
BACKGROUND: Pressure-based physiological evaluation of coronary artery disease is well established, but its application is limited in left main coronary artery (LMCA) disease. Our aim was to invest...
Watch the latest OPCI Journal Club! Divaka Perera presents “Pressure-Derived Indices in the Left Main Coronary Artery: Insights from Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels.” Featuring panelists @ziadalinyc @DrAllenJ @ESHLOF @JWMoses.
0
6
11
Watch the latest OPCI Journal Club! Divaka Perera presents “Pressure-Derived Indices in the Left Main Coronary Artery: Insights from Comprehensive In Vivo Hemodynamic Studies of Diseased and Unobstructed Vessels.” Featuring panelists @ziadalinyc @DrAllenJ @ESHLOF @JWMoses.
2
8
23
🫶🏼Intravascular imaging (IVI) is a class I indication for LM, complex PCI! 🫶🏼The use of IVI in the U.S still remains low! 🫶🏼Calling all ICs: @SCAI wants ur input to understand barriers to using coronary IVI! 🫶🏼Pls take a survey on the topic here👉
1
4
15
Watch the latest OPCI Journal Club presented by Sunil Rao: ACC/AHA ACS Guidelines. Featuring panelists @ziadalinyc @ESHLOF @DrAllenJ @JWMoses and Beatriz Vaquerizo. https://t.co/zZn7TtFGzh
1
9
31
Save the Date: OPCI Structural Complications Summit 2026! January 16-17 📅 | Salt Lake City 🏔️ The 2nd annual Structural Complications Summit is an opportunity for interventional cardiologists, imagers, cardiothoracic surgeons, and fellows to share, learn, and innovate through
0
7
13
If you believe coronary care can be better, OPCI Michigan Clinical Mastery Summit is YOUR 🫵 space to learn, collaborate, and lead that change. Register Now | November 22, Detroit. https://t.co/UDKlUcRCgU ⭐️Special Incentive For Fellows Traveling More Than 2 Hours**
0
3
7
Calling all fellows, ICs, and imagers! Join us for the OPCI Michigan Clinical Mastery Summit - November 22! 🗓️ https://t.co/D6Lqon22fr The summit is more than an educational event, it’s a commitment to raising the standard of care. If you believe coronary care can be better,
0
1
4
🚀 LBT from ESC: ⚠️ AI allows prognostication through automated TCFA identification. Performance at least comparable to core lab. Full pullback analysis improves discriminatory value. 📰 Now available in the European Heart Journal https://t.co/kPJGQZyuen
@ehj_ed @escardio
academic.oup.com
AbstractBackground and Aims. Coronary thin-cap fibroatheromas (TCFA) are associated with adverse outcome, but identification of TCFA requires expertise and
How A.I. of coronary artery images can detect subsequent risk of heart attacks and cardiovascular events better than standard methods without A.I. https://t.co/C9w1PPOYdV
0
3
4